Search
Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.
A study from MSK takes a deeper look at some of the causes of secondary leukemia.
it means to survive cancer and learn how MSK is honoring all cancer survivors this year during National Cancer Survivor Month.
Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.
In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.
Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.
New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.
New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.